For a long time, proton therapy wasn’t available for many cancer patients due to the footprint of traditional proton therapy…
A recent Zacks Small-Cap Research report outlines a number of key milestones that position Soligenix for a potentially eventful period…
Glioblastoma is a deadly type of brain cancer which progresses rapidly and kills victims within months. For nearly two decades, no significant progress has…
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF)and may include paid advertising. Workplace substance misuse costs U.S.…
The immune system is capable of identifying and attacking cancer cells in the body. This process depends on the tumor producing…
LIXT is advancing its lead compound LB-100 across different clinical programs aimed at difficult-to-treat cancers The company’s acquisition of Liora…
LIXT is advancing its lead candidate LB-100, a first-in-class therapy designed to enhance the effectiveness of existing cancer treatments The…
The shares of health insurers in the U.S. recorded gains after the Trump administration announced 2027 payment rate increases for Medicare Advantage that were higher than…
Cancer research often relies on massive and complex datasets, which can take time and effort to sift through manually. The…
Researchers at the University of Calgary in Canada are conducting further trials after early studies revealed that vitamin B3, or niacin, holds…